A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
A Phase II, Single-Center, Randomized, Blinded, Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody Injection in Healthy Subjects
Epistemonikos ID: df3638076dd8496537f1b33f57d21cf7834e0e37
First added on: Mar 04, 2026